IMMUNICON CORP·4

Apr 23, 10:46 AM ET

COOL JONATHAN 4

4 · IMMUNICON CORP · Filed Apr 23, 2004

Insider Transaction Report

Form 4
Period: 2004-04-21
Transactions
  • Conversion

    Series F Convertible Preferred Stock

    2004-04-211,250,0000 total(indirect: By Foundation)
    Common Stock (833,334 underlying)
  • Conversion

    Common Stock

    2004-04-21+833,334833,334 total(indirect: By Foundation)
Footnotes (2)
  • [F1]All of the outstanding shares of the Issuer's Series F Convertible Stock converted automatically on a 1-for1 1/2 basis into Common Stock of the Issuer at the closing of the Issuer's initial public offering.
  • [F2]Foundation Medical Partners, L.P. is the direct beneficial owner of these shaers. The reporting person is a managing member of Foundation Medical Managers, LLC, which, by virtue of an agreement with the reporting person, is affiliated with Foundation Medical Management Company. Foundation Medical managers, LLC is the general partner of Foundation Medical Partners, L.P. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_39228

    POA DOCUMENT